Literature DB >> 12049539

Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery.

Mercedeh Baghai1, Geoffrey B Thompson, William F Young, Clive S Grant, Virginia V Michels, Jon A van Heerden.   

Abstract

HYPOTHESIS: Von Hippel-Lindau disease (VHL) is an autosomal-dominant disorder characterized by benign and malignant tumors involving the central nervous system, kidneys, pancreas, adrenal glands, and paraganglia. Appropriate management of pheochromocytomas and paragangliomas in VHL is evolving as we better understand the genetics and natural course of the disease and master advanced surgical techniques for adrenalectomy.
DESIGN: Retrospective chart review.
SETTING: Tertiary referral center. PATIENTS: A total of 109 patients identified at the Mayo Clinic, Rochester, Minn, with VHL (60 males and 49 females) between January 1, 1975, and June 30, 2000. Seventeen patients (16%) had an identifiable adrenal mass and 3 patients had paragangliomas. Follow-up was complete in all but 2 patients. MAIN OUTCOME MEASURES: Clinical presentation, preoperative evaluation, surgical management, and outcome.
RESULTS: Three patients with paragangliomas and 13 of 17 patients with adrenal masses underwent surgical resection. Median age at time of diagnosis was 30 years (range, 16-47 years); 8 (40%) were asymptomatic. Fractionated urinary catecholamine and metanephrine concentrations were normal in one third of patients. Computed tomographic scanning identified 20 (83%) of 24 tumors. Adrenalectomies were performed as unilateral or bilateral, open or laparoscopic, and, finally, total or cortical-sparing. Seven (50%) of the patients underwent other concurrent abdominal procedures. There were no deaths, with an overall operative morbidity of 2 patients (14%). Only the 2 patients in whom bilateral total adrenalectomies were performed became corticosteroid dependent. No recurrences have been noted to date.
CONCLUSIONS: A multidisciplinary approach is imperative for proper examination and monitoring of patients with VHL. Evaluation should begin early in life and always before elective surgery and childbirth. All adrenal masses in patients with VHL should be thoroughly evaluated and most should be resected. Early intervention and advanced surgical techniques better allow for cortical-sparing and laparoscopic procedures. With low recurrence rates, corticosteroid independence can be maintained for prolonged periods.

Entities:  

Mesh:

Year:  2002        PMID: 12049539     DOI: 10.1001/archsurg.137.6.682

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  18 in total

1.  Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.

Authors:  Raouf Seyam; Mahmoud I Khalil; Mohamed H Kamel; Waleed M Altaweel; Rodney Davis; Nabil K Bissada
Journal:  Int Urol Nephrol       Date:  2019-01-08       Impact factor: 2.370

2.  Genotype-phenotype correlations of pheochromocytoma in two large von Hippel-Lindau (VHL) type 2A kindreds with different missense mutations.

Authors:  Sarah M Nielsen; Wendy S Rubinstein; Darcy L Thull; Michaele J Armstrong; Eleanor Feingold; Michael T Stang; James R Gnarra; Sally E Carty
Journal:  Am J Med Genet A       Date:  2011-01       Impact factor: 2.802

Review 3.  Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.

Authors:  P Björklund; K Pacak; J Crona
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

Review 4.  [Recurrent operations on the adrenal glands].

Authors:  M Brauckhoff; H Dralle
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

5.  Laparoscopic adrenal-sparing surgery: personal experience, review on technical aspects.

Authors:  Giuseppe Cavallaro; Claudio Letizia; Andrea Polistena; Giorgio De Toma
Journal:  Updates Surg       Date:  2011-02-11

6.  Epidemiological study of a von Hippel-Lindau family in northwest China.

Authors:  Jingyao Zhang; Dapeng Wu; Hong Ai; Jigang Bai; Shunbin Dong; Qinling Yang; Kai Qu; Lei Zhou; Xinsen Xu; Chang Liu
Journal:  Front Med       Date:  2013-07-05       Impact factor: 4.592

Review 7.  Von Hippel-Lindau disease: a single gene, several hereditary tumors.

Authors:  J Crespigio; L C L Berbel; M A Dias; R F Berbel; S S Pereira; D Pignatelli; T L Mazzuco
Journal:  J Endocrinol Invest       Date:  2017-06-06       Impact factor: 4.256

8.  Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup.

Authors:  Jihane N Benhammou; Ronald S Boris; Karel Pacak; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-09-17       Impact factor: 7.450

Review 9.  Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician.

Authors:  Alexis Teplick; Megan Kowalski; Jaclyn A Biegel; Kim E Nichols
Journal:  Eur J Pediatr       Date:  2011-01-06       Impact factor: 3.183

Review 10.  Von Hippel-Lindau Disease.

Authors:  Jennifer J Findeis-Hosey; Kelly Q McMahon; Sarah K Findeis
Journal:  J Pediatr Genet       Date:  2016-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.